Allogene疗法(ALLO)

Allogene疗法(ALLO)2020-10-14 07:36

$Allogene疗法(ALLO)$ 内部交易: 2020-10-12,Chief Technical Officer,MOORE ALISON ,卖出,24233普通股, $42.00查看全文

当期报告

Allogene疗法(ALLO)2021-11-05 04:21

$Allogene疗法(ALLO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001737287-21-000049 Act: 34 Size: 252 KB 网页链接查看全文

季度财报

Allogene疗法(ALLO)2021-11-05 04:27

$Allogene疗法(ALLO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001737287-21-000051 Act: 34 Size: 6 MB 网页链接查看全文

保密处理信息

Allogene疗法(ALLO)2021-10-25 21:27

$Allogene疗法(ALLO)$ CT ORDER Confidential treatment order Accession Number: 9999999997-21-005550 Act: 33 Size: 159 KB 网页链接查看全文

禅禅流水2020-08-09 21:30

在CD19靶点上ALLOGENE（$Allogene疗法(ALLO)$ ）已经让我们看到了CAR-T 2.0版本的曙光，异体通用型CAR-T未来极有可能降维打击现有两款CAR-T:YESCARTA和KYMRIAH。去年业内还有人断定异体通用道路走不通。$金斯瑞生物科技(01548)$ $传奇生物(LEGN)$ CAR-T也应该未雨绸缪，守土有责，不能丢失BCMA阵地查看全文

TearsForFears2020-08-04 22:57

$Allogene疗法(ALLO)$ @美股马甲 关注过这个吗， Kite原班人马查看全文

一念一菩提2021-10-08 22:20

$Allogene疗法(ALLO)$ 老神仙居然有这么大挫折查看全文

深入潜意识的理性2021-10-09 09:24

$Allogene疗法(ALLO)$ 网页链接查看全文

深入潜意识的理性2021-10-09 09:46

$Allogene疗法(ALLO)$ 可能是慢病毒载体的锅...查看全文

持股变动声明

Allogene疗法(ALLO)2021-10-05 06:03

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001214659-21-010210 Size: 5 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-17 05:36

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000025 Size: 8 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-17 05:12

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000024 Size: 6 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-17 04:57

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000492 Size: 5 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-17 04:51

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000491 Size: 5 KB 网页链接查看全文

当期报告

Allogene疗法(ALLO)03-11 05:06

$Allogene疗法(ALLO)$ 8-K Current report, item 7.01 Accession Number: 0001737287-23-000023 Act: 34 Size: 165 KB 网页链接查看全文

员工持股计划

Allogene疗法(ALLO)03-01 05:36

$Allogene疗法(ALLO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001737287-23-000020 Act: 33 Size: 133 KB 网页链接查看全文

年度财报

Allogene疗法(ALLO)03-01 05:27

$Allogene疗法(ALLO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001737287-23-000018 Act: 34 Size: 12 MB 网页链接查看全文

当期报告

Allogene疗法(ALLO)03-01 05:12

$Allogene疗法(ALLO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001737287-23-000017 Act: 34 Size: 267 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)02-15 06:18

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000317 Size: 4 KB 网页链接查看全文

超过5%股东持股披露「修订」

Allogene疗法(ALLO)02-14 05:36

$Allogene疗法(ALLO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-035914 Act: 34 Size: 93 KB 网页链接查看全文

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000025 Size: 8 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000024 Size: 6 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000492 Size: 5 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000491 Size: 5 KB 网页链接

当期报告

$Allogene疗法(ALLO)$ 8-K Current report, item 7.01 Accession Number: 0001737287-23-000023 Act: 34 Size: 165 KB 网页链接

员工持股计划

$Allogene疗法(ALLO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001737287-23-000020 Act: 33 Size: 133 KB 网页链接

年度财报

$Allogene疗法(ALLO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001737287-23-000018 Act: 34 Size: 12 MB 网页链接

当期报告

$Allogene疗法(ALLO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001737287-23-000017 Act: 34 Size: 267 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000317 Size: 4 KB 网页链接

超过5%股东持股披露「修订」

$Allogene疗法(ALLO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-035914 Act: 34 Size: 93 KB 网页链接